Skip to content

Influences on the nutrition statuses and clinical outcomes of early use of opioid to contro loral mucosa pain induced by irradiation in nasopharyngeal carcinoma patients

Influences on the nutrition statuses and clinical outcomes of early use of opioid to contro loral mucosa pain induced by irradiation in nasopharyngeal carcinoma patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13005175
Enrollment
Unknown
Registered
2013-08-24
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma

Interventions

Study group:paregoric for mild pain
control group:paregoric for moderate level of pain

Sponsors

Affiliated Cancer Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Histological confirmed nasopharyngeal carcinoma; 2. Without historic chronic pain, no depend on analgesic drugs, no historic opioids intaken; 3. Plan to receive radical radiation therapy, newly to radiation for head and neck; 4. Aged older or equal to 18 years old; 5. Could understand and cooperate to accomplish pain evaluation and observation scales; 6. Sufficient liver and kidney function: ALT or AST less than 2.5*ULN, serum creatinine less than 1.5*ULN; 7. Without other serious critical organ dysfunction, such as heart or lung dysfunction; 8. PS score less than 2 (ECOG); 9. Voluntary to participate and sign informed consent document; 10. Obey the rules of trail; could be followed-up on time.

Exclusion criteria

Exclusion criteria: 1. Excluded by inclusion criteria; 2. Known or suspected allergy to NSAID or opioid medicine; 3. Unable to complete the follow-up; 4. Severe uncontrollable infections of medical disorders; 5. Major organ including heart, lung, kidney, or liver dysfunction; 6. With pathophysiological factors affecting drug absorption, distribution, metabolism or excretion.

Design outcomes

Primary

MeasureTime frame
Numeric rating scale;BMI Body Mass Index;

Secondary

MeasureTime frame
Hemoglobin;albumin;quality of lfe score;overall survival;medical outcomes study sleep scale;

Countries

China

Contacts

Public ContactChen Dong-ping
chen_dpgz@163.com+86 020-66673665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026